Amgen Interview Preparation

Biotech / Pharma · Hyderabad

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat heart disease, obesity and obesity-related conditions, rare diseases, inflammatory conditions and cancer. Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. We have a presence in approximately 100 countries worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on four therapeutic areas, general medicine, rare disease, inflammation, and oncology, delivering innovative medicines to help make people's lives easier, fuller and longer. We pursue new ways to do science using tools like AI, generative biology and human data to discover what is not yet known and develop new precision medicines to fight the world’s toughest diseases. Many of Amgen's medicines are made through a highly complex process involving living cells. We aim to deliver for "every patient, every time", and we have a long-running reputation for the reliability of our supply chain. Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines. We also help build a better world by focusing on environmental, social and governance issues that matter most to our business and our stakeholders. The capabilities we are building across science, technology, and manufacturing are enabling us to move faster, operate more efficiently, and reach more patients than ever before. With a diversified portfolio, strong commercial performance, and a deep and advancing pipeline, we are executing on our strategy to deliver meaningful innovation for patients and attractive long-term growth for shareholders. Amgen strives to serve patients by